Status:
RECRUITING
rTMS Efficacy Coupled With Mirror Therapy
Lead Sponsor:
Centre Hospitalier Universitaire de Saint Etienne
Conditions:
Neuropathic Pain
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Neuropathic pain is particularly difficult to treat with classic first-line drugs. Neuromodulation techniques using repetitive transcranial magnetic stimulation (rTMS) are useful alternative, but ther...
Detailed Description
This project introduces a new research question that incorporates virtual reality mirror therapy into an established treatment protocol of repetitive transcranial magnetic stimulation (rTMS) for neuro...
Eligibility Criteria
Inclusion
- Clinical symptoms typical of neuropathic pain
- Refractory to drug therapies
- Lasting for at least 6 months, with a moderate to severe pain intensity (≥4/10 on Visual Analog Scale, VAS) and a stable pain treatment since 1month at least
- Having right to health benefits
Exclusion
- Ferromagnetic components and implanted microprocessors (i.e. cochlear implants)
- Drug-resistant or active epilepsy, pacemaker, pregnancy, ongoing depression or personality troubles, and ongoing opioid treatment.
- Any other contraindications to MRI scanner (e.g., claustrophobia, etc.).
Key Trial Info
Start Date :
October 27 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT04867187
Start Date
October 27 2022
End Date
April 1 2027
Last Update
April 15 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Neurologique Pierre Wertheimer
Bron, France, 69500
2
Centre Hospitalier Universitaire de Saint-Etienne
Saint-Etienne, France, 42055